SCHEMBL8616965

SCHEMBL8616965

CC(=O)Oc1cc(OCc2ccccn2)cc(F)c1Nc1ncnc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 8/20 0.48
EGFR P00533 8/20 0.48
LCK P06239 1/20 0.48
ERBB4 Q15303 1/20 0.46
MAPT P10636 3/20 0.43
MAPK1 P28482 3/20 0.43
KDM4E B2RXH2 2/20 0.43
HPGD P15428 2/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
AURKA O14965 1/20 0.42
RPS6KB1 P23443 1/20 0.42
ABCG2 Q9UNQ0 3/20 0.40
KCNH2 Q12809 1/20 0.40
DYRK3 O43781 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8618248 0.86 EGFR (0.52) ERBB2EGFRLCKERBB4MAPK1
SCHEMBL8615603 0.82 EGFR (0.43) ERBB2EGFRLCKERBB4MAPK1
SCHEMBL8616130 0.80 EGFR (0.52) ERBB2EGFRLCKERBB4MAPT
SCHEMBL8309481 0.79 EGFR (0.50) ERBB2EGFRLCKERBB4MAPT
SCHEMBL8309434 0.72 EGFR (0.66) ERBB2EGFRLCKERBB4ABCG2
SCHEMBL8306485 0.72 EGFR (0.53) ERBB2EGFRLCKERBB4MAPT
SCHEMBL8617057 0.72 EGFR (0.56) ERBB2EGFRLCKERBB4MAPK1
SCHEMBL8307584 0.71 ERBB2 (0.68) ERBB2EGFRLCKERBB4AURKA
SCHEMBL8621541 0.69 EGFR (0.55) ERBB2EGFRLCKERBB4MAPK1
SCHEMBL8306919 0.69 KDR (0.65) ERBB2EGFRERBB4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821246-A USEFUL AS TYROSINE KINASE INHIBITORS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER ZENECA LIMITED (GB) 1998-10-13 US disclosed